Serum phosphorylated neurofilament heavy chain as a marker of axonal injury and disease severity in multiple sclerosis patients

Assessment of Serum Neurofilament Light Chain Protein in Multiple Sclerosis Patients

SERUM PHOSPHORYLATED NEUROFILAMENT-HEAVY CHAIN LEVELS IN MULTIPLE SCLEROSIS PATIENTS

Role of Neurofilament Light Chain in Relapsing Remitting Multiple Sclerosis Patients

Neurofilaments as a biomarker of axonal loss in multiple sclerosis

SERUM LACTATE AS A BIOMARKER IN MULTIPLE SCLEROSIS

Serum Soluble CD163 as a Marker of Activity in MS Patients

Serum biomarkers in Alzheimer’s disease

An Updated Insight about Biomarkers of Multiple Sclerosis

The association of Inflammatory markers and ICAM-1 with neurological disabilities in Relapsing Remitting Multiple Sclerosis (RRMS) patients